Functional Electronic Stimulated Rehabilitation Application for Treatment in patients with cerebrovascular disorders

Kobayashi Yasuyo0 个研究点目标入组 16 人开始时间: 2022年2月1日最近更新: 2024年4月23日

适应症

试验速览

暂无简介。

•1. Within 1 month of cerebrovascular event (cerebral infarction, cerebral hemorrhage, subarachnoid hemorrhage)
•2. With upper limb Brunnstrom stage(BRS)2-4
•3. Who are 20 years of age or older at the time of obtaining informed consent
•4. Whose consent to participate in this clinical study and the informed consent of the patient have has been obtained in writing

•1. Received treatments, such as botulinum therapy, repeated transcranial magnetic stimulation, transcranial direct current stimulation within 90 days of obtaining consent
•2. With a history of surgery(including device therapy)or intravenous t-PA for cerebrovascular event (cerebral infarction, cerebral hemorrhage, subarachnoid hemorrhage)
•3.Cognitive decline(Mini-Mental State Examination(MMSE)is 21 or less)
•4.Severe skin symptoms on the affected upper limb
•5.Have a history of epileptic seizures
•6.With a history of substance abuse or addiction(including alcoholism)at the time of enrollment and within the past year, or patients with complications
•7.Using an implantable cardiac stimulator such as a cardiac pacemaker or an implantable assisted heart
•8.Using deep brain stimulation
•9.With metal(excluding titanium products)implanted in the affected upper limb
•10.Who are pregnant or may become pregnant
•11.Who are judged by doctors to be inappropriate as research subjects

发起方

Kobayashi Yasuyo